Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 25 results:
Author Title Type [ Year] Filters: Keyword is Antirheumatic Agents [Clear All Filters]
Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases..
Ann Rheum Dis. 78(10), 1405-1411.
(2019). Anti-TNF modulation reduces myocardial inflammation and improves cardiovascular function in systemic rheumatic diseases..
Int J Cardiol. 270, 253-259.
(2018). Inducible nitric oxide synthase as a target for osteoarthritis treatment..
Expert Opin Ther Targets. 22(4), 299-318.
(2018).
(2018). Predictors and long-term outcome in Greek adults with juvenile idiopathic arthritis: a 17-year continuous follow-up study..
Rheumatology (Oxford). 56(11), 1928-1938.
(2017). Role of vaccinations and prophylaxis in rheumatic diseases..
Best Pract Res Clin Rheumatol. 29(2), 306-18.
(2015). Cardiovascular risk in psoriatic arthritis: should we focus on hypertension and diabetes only?.
Clin Exp Rheumatol. 32(6), 995.
(2014). Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaboration..
Pediatr Rheumatol Online J. 12, 49.
(2014). Neuropathic pain in osteoarthritis: a review of pathophysiological mechanisms and implications for treatment..
Semin Arthritis Rheum. 44(2), 145-54.
(2014). Secukinumab for ankylosing spondylitis..
Lancet. 383(9919), 780.
(2014). Achievement of clinical remission in patients with juvenile idiopathic arthritis under a 2-10-year Etanercept exposure..
Clin Rheumatol. 32(8), 1191-7.
(2013). Autoimmune thyroiditis-associated encephalopathy without clinical steroid-responsiveness and recovery after cyclophosphamide..
J Neuropsychiatry Clin Neurosci. 25(1), E17-8.
(2013). Leflunomide addition in patients with articular manifestations of psoriatic arthritis resistant to methotrexate..
Rheumatol Int. 33(11), 2917-20.
(2013).
(2013). Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine..
J Neuroimmunol. 250(1-2), 94-8.
(2012). B-cell activating factor levels in rheumatoid arthritis patients in response to treatment with biologics..
J Interferon Cytokine Res. 32(7), 338-40.
(2012). Efficacy of leflunomide addition in relation to prognostic factors for patients with active early rheumatoid arthritis failing to methotrexate in daily practice..
Clin Rheumatol. 31(1), 163-7.
(2012). A prospective open-label clinical trial of efficacy of the every week administration of adalimumab in the treatment of hidradenitis suppurativa..
J Drugs Dermatol. 11(5 Suppl), s15-20.
(2012).
(2012). Association of anti-CCP positivity and carriage of TNFRII susceptibility variant with anti-TNF-α response in rheumatoid arthritis..
Clin Exp Rheumatol. 29(4), 701-4.
(2011). Safety and efficacy of adalimumab treatment in Greek children with juvenile idiopathic arthritis..
Scand J Rheumatol. 40(2), 101-7.
(2011). The effect of anti-TNF treatment on the immunogenicity and safety of the 7-valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis..
Vaccine. 28(31), 5109-13.
(2010). A follow-up study of patients with juvenile idiopathic arthritis who discontinued etanercept due to disease remission..
Clin Exp Rheumatol. 28(6), 919-22.
(2010). Response to rituximab and timeframe to relapse in rheumatoid arthritis patients: association with B-cell markers..
Mol Diagn Ther. 14(1), 43-8.
(2010). Tumor necrosis factor antagonist-associated neutropenia: comment on the article by Hastings et al..
Arthritis Care Res (Hoboken). 62(12), 1813-5; author reply 1815.
(2010).